Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Hodgkin's Disease 2011 NCI 5R01CA131354-03 Inhibitors of Epstein-Barr Virus Nuclear Protein 1 Mediated Latent Infection KIEFF, ELLIOTT BRIGHAM AND WOMEN'S HOSPITAL MA $358,438
Hodgkin's Disease 2011 NCI 5R37CA042245-26 Regulation of replication and latency EBV EBNAs HAYWARD, S JOHNS HOPKINS UNIVERSITY MD $356,292
Hodgkin's Disease 2011 NCI 5R01CA068051-16 Pathogenesis of EBV Infection WANG, FREDERICK BRIGHAM AND WOMEN'S HOSPITAL MA $454,973
Hodgkin's Disease 2011 NCI 5R01CA073507-14 In Vivo Model of Epstein-Barr Virus Latency LONGNECKER, RICHARD NORTHWESTERN UNIVERSITY AT CHICAGO IL $366,175
Hodgkin's Disease 2011 NCI 5R01CA098285-08 Towards a Mouse Model of Classical Hodgkin's Disease and PTLD RAJEWSKY, KLAUS IMMUNE DISEASE INSTITUTE, INC. MA $490,125
Hodgkin's Disease 2011 NCI 5R37CA012055-39 Studies of Epstein-Barr Virus MILLER, I. YALE UNIVERSITY CT $446,398
Hodgkin's Disease 2011 NCI 2P50CA107399-06A1 City of Hope Lymphoma SPORE FORMAN, STEPHEN CITY OF HOPE/BECKMAN RESEARCH INSTITUTE CA $2,185,000
Hodgkin's Disease 2011 NIAID 5R01AI041769-14 Cellular Mechanisms of PTLD in Transplant Recipients MARTINEZ, OLIVIA STANFORD UNIVERSITY CA $408,411
Hodgkin's Disease 2011 NCI 5R01CA138636-02 BETR Therapy for Herpesvirus-Associated Tumors POMPER, MARTIN JOHNS HOPKINS UNIVERSITY MD $553,505
Hodgkin's Disease 2011 NIDCR 5R01DE017336-06 Epigenetic Regulation of Epstein-Barr Virus Latency Programs LIEBERMAN, PAUL WISTAR INSTITUTE PA $311,677
Hodgkin's Disease 2011 NCI 5R01CA124311-05 Regulation of Epstein Barr virus reactivation through the co-activators, CBP/p300 FLEMINGTON, ERIK TULANE UNIVERSITY OF LOUISIANA LA $247,146
Hodgkin's Disease 2011 NCI 5K23CA124465-04 Novel Biologic Therapies for Hodgkin's Lymphoma KASAMON, YVETTE JOHNS HOPKINS UNIVERSITY MD $140,940
Hodgkin's Disease 2011 NIAID 5R03AI085545-02 A FUNCTIONAL STUDY OF UBIQUITIN C-TERMINAL HYDROLASE L1 EXPRESSION IN B-LYMPHOMA SHACKELFORD, JULIA UNIVERSITY OF NORTH CAROLINA CHAPEL HILL NC $73,260
Hodgkin's Disease 2011 NCI 5R01CA133063-04 Discovery of New Treatment Options for EBV-associated Lymphoma and PTLD LONGNECKER, RICHARD NORTHWESTERN UNIVERSITY AT CHICAGO IL $402,448
Hodgkin's Disease 2011 NCI 5R01CA131027-04 Chimeric T Cell for Therpay of Hodgkin Disease SAVOLDO, BARBARA BAYLOR COLLEGE OF MEDICINE TX $308,958
Hodgkin's Disease 2011 NCI 5R01CA140245-02 Low Dose Tamoxifen in Hodgkin Lymphoma Survivors for Breast Cancer Risk Reduction PALOMARES, MELANIE CITY OF HOPE/BECKMAN RESEARCH INSTITUTE CA $600,681
Hodgkin's Disease 2011 NCI 5R01CA127433-05 Signal transduction inhibitor therapy for Lymphoma WITZIG, THOMAS MAYO CLINIC MN $325,779
Hodgkin's Disease 2011 NCI 5R01CA047006-24 Epstein-Barr Virus Nuclear Proteins in B Cell Growth Transformation KIEFF, ELLIOTT BRIGHAM AND WOMEN'S HOSPITAL MA $554,148
Hodgkin's Disease 2011 NHLBI 5R01HL094603-02 Chronic High EBV load and risk of PTLD in Pediatric Heart Transplant Patients METES, DIANA UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $375,145
Hodgkin's Disease 2011 NCI 1R43CA153474-01A1 Virus-Targeted Therapy for Malignancies PERRINE, SUSAN PHOENICIA BIOSCIENCES, INC. MA $288,895
Hodgkin's Disease 2011 NCI 1R13CA159723-01 1st International Symposium on Childhood, Adolescent and Young Adult Hodgkin Lymp METZGER, MONIKA ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $5,000
Hodgkin's Disease 2011 NCI 1R01CA160300-01 Cellular Response to Short Telomeres in B-Cell Lymphoma GREIDER, CAROL JOHNS HOPKINS UNIVERSITY MD $537,001
Hodgkin's Disease 2011 NCI 1R01CA161026-01 Complementary Signaling Pathways In Hodgkin Lymphoma and Related Malignancies SHIPP, MARGARET DANA-FARBER CANCER INSTITUTE MA $449,734
Hodgkin's Disease 2011 NCI 1K05CA160724-01 Survivorship: Mentoring and Bridging Primary Care and Oncology OEFFINGER, KEVIN SLOAN-KETTERING INSTITUTE FOR CANCER RES NY $164,278
Hodgkin's Disease 2011 NCI 1R01CA140337-01A2 Host pathways regulating Epstein-Barr virus-mediated B cell growth transformation LUFTIG, MICAH DUKE UNIVERSITY NC $325,775
Hodgkin's Disease 2011 NCI 1R21CA162002-01 EBV Specific T-cells from 3rd party donors for treatment of EBV-associated malign O'REILLY, RICHARD SLOAN-KETTERING INSTITUTE FOR CANCER RES NY $375,713
Hodgkin's Disease 2011 NCI 1R01CA162964-01 Antibody-interferon fusion proteins for treatment of B-cell malignancies MORRISON, SHERIE UNIVERSITY OF CALIFORNIA LOS ANGELES CA $319,550
Hodgkin's Disease 2011 NCI 5P01CA094237-09 0001 OVERCOMING TUMOR EVASION MECHANISMS IN HODGKIN DISEASE ROONEY, CLIONA BAYLOR COLLEGE OF MEDICINE TX $271,819
Hodgkin's Disease 2011 NCI 5P01CA094237-09 0002 THE ROLE AND MECHANISMS OF CD4+ T CELLS IN ANTITUMOR IMMUNITY WANG, RONGFU BAYLOR COLLEGE OF MEDICINE TX $269,219
Hodgkin's Disease 2011 NCI 5P01CA078902-13 8825 Allogeneic HCT for Hematologic Malignancies: Pharmacologic Manipulations MALONEY, DAVID FRED HUTCHINSON CANCER RESEARCH CENTER WA $184,831
Hodgkin's Disease 2011 NCI 3R01CA133063-04S1 Discovery of New Treatment Options for EBV-associated Lymphoma and PTLD LONGNECKER, RICHARD NORTHWESTERN UNIVERSITY AT CHICAGO IL $79,631
Hodgkin's Disease 2011 NCI 5P01CA022443-34 0013 Mechanisms of Reactivation of Epstein-Barr Virus from Latency to Lytic Replicatio MERTZ, JANET UNIVERSITY OF WISCONSIN MADISON WI $310,628
Hodgkin's Disease 2011 NCI 5P01CA015396-36 0020 Hodgkin's Lymphoma Stem Cells AMBINDER, RICHARD JOHNS HOPKINS UNIVERSITY MD $375,115
Hodgkin's Disease 2011 NCI 5P30CA124435-05 6484 Lymphoma LEVY, RONALD STANFORD UNIVERSITY CA $15,416
Hodgkin's Disease 2011 NCI 5P50CA097274-10 0002 P2 - Signal Transduction Inhibitor Therapy for Lymphoma WITZIG, THOMAS UNIVERSITY OF IOWA IA $281,849
Hodgkin's Disease 2011 NCI 5P50CA136411-03 5412 Epigenetic-based therapy of Hodgkin lymphoma YOUNES, ANAS UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $65,809
Hodgkin's Disease 2011 NCI 5P50CA126752-05 0001 Immunotherapy for Hodgkin's Disease ROONEY, CLIONA BAYLOR COLLEGE OF MEDICINE TX $236,989
Hodgkin's Disease 2011 NCI 5P50CA126752-05 0003 T Cell Therapy Targeting LMP1 and 2 in EBV+VE Lymphomas GOTTSCHALK, STEPHEN BAYLOR COLLEGE OF MEDICINE TX $245,499
Hodgkin's Disease 2011 NCI 1ZIABC010603-08 Receptor-directed Therapy JANIK, JOHN NIH $497,717
Hodgkin's Disease 2011 NCI 1ZIABC011070-04 Hematopathology Diagnosis JAFFE, ELAINE NIH $574,046
Hodgkin's Disease 2011 NCI 1ZIABC011338-02 Functional Analysis of the REL Transcription Factors in B-Cells LEWIS, BRIAN NIH $295,053
Hodgkin's Disease 2011 NCI 1ZIABC011417-01 New Chimeric Antigen Receptors for Treating Hematologic Malignancies KOCHENDERFER, JAMES NIH $156,999
Hodgkin's Disease 2011 NCI 1ZIACP010131-16 Studies of Populations Exposed to Therapeutic Medical Radiation and Other Agents BERRINGTON, AMY NIH $2,973,851
Hodgkin's Disease 2011 NCI 1ZIACP010214-02 Microbes and Human Malignancies GOEDERT, JAMES NIH $710,295
Hodgkin's Disease 2011 NCI 1ZIASC000550-31 Lymphoma Disease Discovery and Defintion JAFFE, ELAINE NIH $1,148,092
Hodgkin's Disease 2011 NCRR 5M01RR000188-47 6618 ADMINISTRATION OF TGF-B RESISTANT LMP2A-SPECIFIC CYTOTOXIC T-LYMPHOCYTES TO P BOLLARD, CATHERINE BAYLOR COLLEGE OF MEDICINE TX $14,643
Hodgkin's Disease 2011 NCRR 5M01RR000188-47 6700 CLINICAL TRIAL: THE ADMINISTRATION OF NEOMYCIN RESISTANCE GENE MARKED EBV SPECI BOLLARD, CATHERINE BAYLOR COLLEGE OF MEDICINE TX $395
Hodgkin's Disease 2011 NCRR 5M01RR000188-47 6706 CLINICAL TRIAL: NEOMYCIN RESISTANCE LMP2A SPECIFIC CYTOTOXIC T-LYMPHOCYTES FOR BOLLARD, CATHERINE BAYLOR COLLEGE OF MEDICINE TX $41,950
Hodgkin's Disease 2011 NCRR 5P51RR000168-50 7573 PATHOGENESIS OF EPSTEIN-BARR VIRUS INFECTION WANG, FREDERICK HARVARD UNIVERSITY (MEDICAL SCHOOL) MA $68,415


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer